These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7134032)

  • 1. The stability and metabolism of intravenously administered neurotensin in the rat.
    Aronin N; Carraway RE; Ferris CF; Hammer RA; Leeman SE
    Peptides; 1982; 3(4):637-42. PubMed ID: 7134032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography.
    Draviam EJ; Upp JR; Greeley GH; Townsend CM; Thompson JC
    Dig Dis Sci; 1990 Feb; 35(2):200-4. PubMed ID: 2302977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.
    Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR
    J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors.
    Shulkes A; Bijaphala S; Dawborn JK; Fletcher DR; Hardy KJ
    J Clin Endocrinol Metab; 1984 May; 58(5):873-9. PubMed ID: 6707191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular handling of neurotensin in the rat kidney as studied by micropuncture and HPLC.
    Bjerke T; Christensen EI; Boye N
    Am J Physiol; 1989 Jan; 256(1 Pt 2):F100-6. PubMed ID: 2912155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release and degradation of neurotensin during perfusion of rat small intestine with lipid.
    Ferris CF; Carraway RE; Hammer RA; Leeman SE
    Regul Pept; 1985 Oct; 12(2):101-11. PubMed ID: 3840906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ and plasma metabolism of neurotensin in sheep.
    Shulkes A; Fletcher DR; Hardy KJ
    Am J Physiol; 1983 Nov; 245(5 Pt 1):E457-62. PubMed ID: 6638173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material.
    Carraway R; Hammer RA; Leeman SE
    Endocrinology; 1980 Aug; 107(2):400-6. PubMed ID: 7389661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The simultaneous determination of neurotensin and its major fragments by on-line trace enrichment HPLC with electrochemical detection.
    Kilts CD; Knight DL; Nemeroff CB
    Life Sci; 1996; 59(11):911-20. PubMed ID: 8795702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between lower esophageal sphincter (LES) pressure and the plasma concentration of neurotensin during intravenous infusion of neurotensin(1-13) and (Gln4)neurotensin(1-13) in man.
    Theodorsson-Norheim E; Thor K; Rosell S
    Acta Physiol Scand Suppl; 1983; 515():29-35. PubMed ID: 6578671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for biological activity of two N-terminal fragments of neurotensin, neurotensin1-8 and neurotensin1-10.
    Hernandez DE; Richardson CM; Nemeroff CB; Orlando RC; St-Pierre S; Rioux F; Prange AJ
    Brain Res; 1984 May; 301(1):153-6. PubMed ID: 6329440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal neurotensin fragment, NT1-11, inhibits cortisol secretion by human adrenocortical cells.
    Sicard F; Contesse V; Lefebvre H; Ait-Ali D; Gras M; Cartier D; Decker A; Chartrel N; Anouar Y; Vaudry H; Delarue C
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3131-7. PubMed ID: 16705076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of neurotensin by isolated perfused rat kidney.
    Gillatt DJ; Shulkes A; Read DM; Hardy KJ
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E930-6. PubMed ID: 2360626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin metabolism in the rat: contribution of the kidney.
    Shulkes A; Englin I; Read D; Hardy KJ
    Peptides; 1987; 8(6):961-5. PubMed ID: 3126491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic metabolism of neurotensin.
    Brook CW; Shulkes A; Sewell RB; Smallwood RA
    Endocrinology; 1987 Apr; 120(4):1397-402. PubMed ID: 3549259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact neurotensin (NT) in human plasma: response to oral feeding.
    Shaw C; Buchanan KD
    Regul Pept; 1983 Oct; 7(2):145-53. PubMed ID: 6197723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal.
    Lee YC; Allen JM; Uttenthal LO; Roberts PM; Gill SS; Bloom SR
    Dig Dis Sci; 1985 Feb; 30(2):129-33. PubMed ID: 3838153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components.
    Hammer RA; Carraway RE; Leeman SE
    J Clin Invest; 1982 Jul; 70(1):74-81. PubMed ID: 7085889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
    Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
    Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.